FDA approves reverse-anticoagulant drug Kcentra

When patients medicated for atrial fibrillation are brought to emergency departments with severe bleeding, reversing the effects of the anticoagulants they take can be difficult. The FDA has just approved a new product, Kcentra, for this purpose in some patients.

( Lawrence K. Ho / November 9, 2010 )

When patients medicated for atrial fibrillation are brought to emergency departments with severe bleeding, reversing the effects of the anticoagulants they take can be difficult. The FDA has just approved a new product, Kcentra, for this purpose in some patients.

  • Email E-mail
  • add to Twitter Twitter
  • add to Facebook Facebook

PLAN AHEAD

Top Trending Videos